Search
Search
Digital PCR (dPCR) is a leading technology for detection and quantification of rare mutations and target sequences in oncology research. Whether you are using precious biological samples to unlock the mysteries of tumor growth or generating data to tumor growth or to study biomarkers that may one day inform treatment decisions, our menu of pre-designed, pre-tested, and pre-qualified Absolute Q and TaqMan multiplex oncology assays for dPCR take the guesswork out of assay design and optimization. Combined with the precision, flexibility, and simplicity of the Absolute Q dPCR System, multiplex oncology assays for dPCR give you the confidence you need, when it matters most.
Since dPCR utilizes the same biochemistry as qPCR to amplify and detect target sequences, existing well-designed dPCR assays as well as all 20 million+ TaqMan Assays can be transitioned to the Absolute Q dPCR System with minimal optimization, allowing you the freedom and confidence to choose the best assay to achieve your research goals.
Absolute quantification using dPCR eliminates the need for a standard curve, improving both the accuracy and reproducibility of rare-target concentration measurement. dPCR also enables detection of ultra-rare targets by leveraging pooling data to overcome limitations of sample input volume and concentration.
Technical Note: Improve sensitivity for rare targets by pooling digital PCR data
For more technical resources for dPCR, check out our Taq Academy.
For Research Use Only. Not for use in diagnostic procedures.